Home
General Information to Patients
ALL
AML
Anus
Bladder/urothelial
Brain
Breast
Cervix
CLL
CML
Colon and Rectum
GIST
Hairy Cell Leuk.
Head and Neck
Hemato/Graft
Hepatic Ducts
Hodgkin
Kidney
Liver
Melanoma
Mesothelioma
MPN
MDS
Myeloma
Neuroendocr. T
NSCLC
NHL
Oesophagus
Ovary
Pancreas
Prostate
Sarcoma
Skin
SCLC
Solid Tumors
Stomach
Testis
Thyroid
Uterine Sarcoma
Uterus Lining
Clinical Trials
View all
Search
Videos for patients
Oral therapy
Chemo & Immunotherapy
Immunotherapy (professionals)
Guidelines : Management of Toxicities
Administrative Tools
Recherche
Home
Infos/documents - Immunotherapy
Guidelines : Management of Toxicities
Administrative Tools
IMMUNOTHERAPY
Guidelines : Management of Toxicities
ASCO - Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy (November 2021)
ASCO - Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy (December 2021)
ESMO - Management of toxicities from immunotherapy (octobre 2022)
MASCC - 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors (September 2020)
NCCN - Management of Immunotherapy-Related Toxicities ***connexion requise*** (December 2024)
Administrative Tools
Carte Immunothérapie à imprimer
Étiquettes à imprimer sur feuille d'étiquettes Avery 5163 et apposer dans le passeport en oncologie remis au patient
Immunotherapy card to be printed
Groupe d'étude en oncologie du Québec